That is necessary, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (first lady). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're developed to do. This was a breakthrough practically nobody discovered. But it's going to have profound implications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of financial investment opportunities in this area, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech stock). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back maybe considerably before going greater - diplomatic relations. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. However that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown genetic sequencer stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many fantastic personal companies on the verge of striking the public markets And I've been working on a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (future report review). And when it concerns tech investing, we leave it to the professionals. Luckily, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (jeff brown genetic sequencer stock). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing exponential development and producing incredible chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. what is the legacy report predicting. However regardless of what lots of readers may think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown latest prediction). Losing 2 months of production and sales really impacts how many 5G devices are sold in the calendar year. When you think about all of that, selling 250 million units is impressive. More notably, the hold-ups triggered by the pandemic created a lots of suppressed demand. And that need is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - last year. And that's not my only 5G prediction When I have actually spoken about 5G in the past, I have actually described its 3 different phases.
In Stage Two, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services start to be used (united arab emirates). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summertime. This starts something of a virtuous cycle: The majority of people do not actually care about the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of incredible applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next crucial technology I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just 3 companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is successfully a greenfield chance.
There's space for numerous companies to exist in this space. longtime readers. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can precisely forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug therapies produced using this technology. This was among those developments that almost no one noticed. However it's going to have extensive ramifications for curing disease. And, of course, there will be lots of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps significantly before going higher. I have actually been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - jeff brown 2021 stock predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. artificial intelligence. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, but we might not independently validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's constantly on the hunt for new chances, and he shares many of his finest picks in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he effectively forecasted some of the greatest economic events of the previous twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal whenever, however Jeff Brown's precise forecasts have actually earned him legions of dedicated followers. That states a lot about his ability. The Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study offers several research services with a wide array of expertises - last week.
The company is also associated with Bonner & Partners, another well-respected research publisher - jeff brown 1 biotech company. On its website, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the best financial investment research study has not been available to private financiers. It has been normally scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. biotech stock. The mission of Brownstone Research study is to make that kind of exclusive research offered to any financiers looking to get an edge in the markets. The objective is easy to provide unique and rewarding financial investment research found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you understand even a bit about the market, you know that he has a credibility as a King Midas of sorts. angel investor. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. the legacy report predictions. could be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 advanced innovations: artificial intelligence and electrical automobiles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the automobile market's Holy Grail. As you know, electric cars and self-driving vehicle stocks have actually been huge this year, but the Wall Street maker has actually approved hype without much tangible outcome. Despite a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the best possibility of putting everything together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would permit you to rent your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the revenues. It sounds insane, however it might be closed than you think.